Baxter announced today that it launched the PerClot absorbable hemostatic powder in the U.S. PerClot, a passive, absorbable hemostatic powder, received FDA approval in May. Artivion developed the powder and transferred full ownership to Baxter as part of a sale agreement struck in July 2021. Artivion designed PerClot to control mild bleeding in specific surgical […]
Blood Management
ReCor Medical is pleased with updated renal denervation guidelines in Europe
ReCor Medical today applauded updated and expanded recommendations for managing arterial hypertension overseas. The European Hypertension Society (ESH) this month issued updated guidelines on the role of renal denervation in the hypertension care pathway. It announced the guidelines at the ESH 32nd Annual Meeting and simultaneously published them in the Journal of Hypertension. These new guidelines serve […]
1,000th implant completed with Sequana Alfapump for treating fluid overload
Sequana Medical announced that it implanted the 1,000th implant of its Alfapump for treating recurrent and refractory ascites. The Ghent, Belgium-based company’s pump treats these fluid overload conditions that arise due to liver cirrhosis and malignant ascites. In addition to the milestone implant, Sequana said it received all administrative clearances to begin its U.S. MOJAVE […]
Medtronic applauds new renal denervation guidelines in Europe
Medtronic issued a statement highlighting its excitement over new renal denervation guidelines in Europe. The European Hypertension Society (ESH) issued updated guidelines on the role of renal denervation in the hypertension care pathway. It announced the guidelines at the ESH 32nd Annual Meeting and simultaneously published them in the Journal of Hypertension. Medtronic said in […]
FDA clears Boston Scientific Embold Soft & Packing coils for embolization procedures
Boston Scientific announced that it received FDA 510(k) clearance for its Embold Soft & Packing coils. Marlborough, Massachusetts-based Boston Scientific designed the coils for use in a variety of embolization procedures. They aid in the minimally invasive treatment for blocking one or more blood vessels, obstructing or reducing blood flow. The procedure stops hemorrhaging, prevents […]
FDA clears enhancements to plasma collection tech from Haemonetics
Haemonetics (NYSE:HAE) announced that the FDA cleared advancements to its NexSys PCS plasma collection system. Enhancements include a new plasma collection bowl and new Express Plus technology, according to a news release. The bowl features a patented design to optimize performance and Express Plus reduces procedure time. Boston-based Haemonetics designed NexSys PCS as a completely […]
Nuwellis, DaVita partner on ultrafiltration therapy pilot program
Nuwellis (Nasdaq:NUWE) announced today that it entered into a supply and collaboration agreement with DaVita (NYSE:DVA). The agreement enables Nuwellis — formerly CHF Solutions — to pilot its Aquadex ultrafiltration therapy within selected U.S. markets. Aquadex, which removes excess fluid from patients suffering from hypervolemia (fluid overload), treats congestive heart failure and related conditions. DaVita […]
Stat Health launches in-ear wearable that measures blood flow
With $5.1 million in seed funding, Stat Health today unveiled a 24/7 in-ear wearable device designed to measure blood flow to the head. J2 Ventures, BonAngels Venture Partners and a diverse group of angel investors backed the company through the seed funding. Stat Health also received grant funding from the U.S. Air Force. Boston-based Stat […]
Inspira Technologies appoints new chief medical officer
Inspira Technologies this week announced it appointed Adi Rizansky Nir as chief medical officer. Nir will play a critical role in overseeing and guiding Inspira’s medical operations and strategic initiatives. She will collaborate closely with the company’s executive leadership team, medical stage and scientific advisory board to develop and implement innovative strategies that enhance patient […]
Onward completes first-in-human use of movement-restoring lead
Onward Medical announced today that it successfully completed the first-in-human use of its investigational ARC-IM lead. Eindhoven, the Netherlands-based Onward designed the lead to restore movement, function and independence in people with spinal cord injury (SCI). The company developed ARC-IM to deliver targeted electrical pulses to the spinal cord. It represents a key component of […]
FDA clears vascular biometric monitor from CardieX
CardieX announced today that it received FDA 510(k) clearance for its Conneqt Pulse vital signs monitor system. Irvine, California-based CardieX designed Pulse for vital signs monitoring for use at home, by clinicians and in clinical trials. It provides measurements of both brachial blood pressure and central blood pressure, plus other vascular health biomarkers. Pulse uses […]